Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT01033058
Eligibility Criteria:
Inclusion Criteria:
* 20-75 years old
* myocardiac ischemia symptom of index event appeared less than 12 hours before enrollment.
* ECG showed elevated ST segment in 3 or more contiguous leads
* diagnosed with acute STEMI
* eligible for primary PCI, and primary PCI is scheduled within 2 hours after enrollment
Exclusion Criteria:
* allergic or experienced serious adverse reaction to HMG-CoA reductase
* pregnancy, lactation, or child bearing potential women without any effective contraception
* accompanied with malignant disease
* active hepatic disease or hepatic dysfunction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT01033058
Study Brief:
Protocol Section:
NCT01033058